← All trials
NCT05142423
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 3, 2021
- Primary completion
- Aug 20, 2022
- Completion date
- Oct 20, 2023
- First posted
- Dec 2, 2021
- Last posted
- Dec 2, 2021
- Enrollment
- 198
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Akeso Pharmaceuticals, Inc.Lead sponsor
- Zhejiang UniversityOverall official - principal investigator
- People's Liberation Army of ChinaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.